• National Taiwan University Hospital, Taiwan
• Immediate Past President of the Taiwanese Dermatological
Association
• Consultant, National Taiwan University Hospital

Dr. Clarisse Mendoza 

Chair of the Immunodermatology
Subspecialty Core Group,
Philippine Dermatological Society

×

• Residency Training Officer & Immunodermatology Unit Head,
Department of Dermatology, Research Institute for Tropical
Medicine

Professor Michael J. Cork, BSc MB PhD FRCP

×

Co-Director of Sheffield Dermatology Research, Department of Infection, Immunity & Cardiovascular
Disease; Faculty of Medicine, Dentistry & Health at the University of Sheffield, UK
Consultant Dermatologist Sheffield Children’s Hospital and Sheffield Teaching Hospitals
Professor Michael J. Cork specialises in treating children and adults with the most severe atopic dermatitis and
sees patients from anywhere in the UK. At Sheffield Children’s Hospital he leads an integrated atopic dermatitis –
allergy – psychiatry service, designed to manage the most complex patients. He leads clinical trials of new
treatments for atopic dermatitis at the Clinical Research Facilities at SCH for children and at STH for adults. He is
Chief Investigator in the UK for many of the trials for new biologics, small molecules and topicals for atopic
dermatitis.
With Dr Simon Danby, they have created a dedicated clinical research facility for skin barrier, biomarker research.
Their Skin Barrier Team have developed a research facility that has developed a unique combination of
techniques to assess how topical wash products, emollients and topical/systemic pharmaceutical agents affect
the integrity of the skin barrier and inflammation in normal and AD skin. These biomarkers are used to assess the
safety and efficacy of treatments for atopic dermatitis. These atopic dermatitis biomarkers are also being used in
experimental medicine clinical trials to stratify patients according to clinical response and safety parameters. This
information can be used to determine how long a treatment should be used for, the optimum dose, the effect on
some comorbidities and inform health economic evaluations.

Professor Michael J. Cork, BSc MB PhD FRCP

×

Co-Director of Sheffield Dermatology Research, Department of Infection, Immunity & Cardiovascular
Disease; Faculty of Medicine, Dentistry & Health at the University of Sheffield, UK
Consultant Dermatologist Sheffield Children’s Hospital and Sheffield Teaching Hospitals
Professor Michael J. Cork specialises in treating children and adults with the most severe atopic dermatitis and
sees patients from anywhere in the UK. At Sheffield Children’s Hospital he leads an integrated atopic dermatitis –
allergy – psychiatry service, designed to manage the most complex patients. He leads clinical trials of new
treatments for atopic dermatitis at the Clinical Research Facilities at SCH for children and at STH for adults. He is
Chief Investigator in the UK for many of the trials for new biologics, small molecules and topicals for atopic
dermatitis.
With Dr Simon Danby, they have created a dedicated clinical research facility for skin barrier, biomarker research.
Their Skin Barrier Team have developed a research facility that has developed a unique combination of
techniques to assess how topical wash products, emollients and topical/systemic pharmaceutical agents affect
the integrity of the skin barrier and inflammation in normal and AD skin. These biomarkers are used to assess the
safety and efficacy of treatments for atopic dermatitis. These atopic dermatitis biomarkers are also being used in
experimental medicine clinical trials to stratify patients according to clinical response and safety parameters. This
information can be used to determine how long a treatment should be used for, the optimum dose, the effect on
some comorbidities and inform health economic evaluations.

Professor Michael J. Cork, BSc MB PhD FRCP

×

Dr Lio is a Clinical Professor of Dermatology at the Icahn School of Medicine at Mount Sinai, New York, USA. Dr Lio is a Fellow of the American Academy of Dermatology, and a Diplomate of the American Board of Dermatology (board-certified in Dermatology), and the founding director of the Chicago Integrative Eczema Center.

Dr Lio has spoken nationally and internationally about eczema and atopic dermatitis, as well as alternative medicine. Dr Lio is a Board member and scientific advisory committee member emeritus for the National Eczema Association, a Member of the American Academy of Dermatology’s Atopic Dermatitis Expert Resource Group and a founding faculty member of the Integrative Dermatology Certificate Program. Dr Lio has over 300 publications and 3 textbooks.